Etaracizumab Uses, Dosage, Side Effects and more
Etaracizumab has been investigated for the treatment of Psoriasis, Renal Cell Carcinoma, Stage IV Renal Cell Cancer, Recurrent Renal Cell Cancer, and Stage III Renal Cell Cancer.
| Attribute | Details |
|---|---|
| Trade Name | Etaracizumab |
| Generic | Etaracizumab |
| Etaracizumab Other Names | Etaracizumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
